Conference - Banff, Canada
While monoclonal antibodies are now an established class of drugs in oncology and inflammation, exciting progress has been recently made on next generation, engineered therapeutic antibodies and alternative immunological scaffolds, with first examples from this class being recently approved by FDA and EMA. This symposium will review progress in this area including lessons learned in the clinic and how this can be applied to new targets and drug candidates.
Sun, Feb 08, 2015 - Fri, Feb 13, 2015
Fairmont Banff Springs
Banff, Canada
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.